Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers
- PMID: 22269658
- DOI: 10.1097/BOR.0b013e32834ff2e8
Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers
Abstract
Purpose of review: To identify the recent data regarding prevalence, incidence, survival, and risk factors for systemic sclerosis (SSc) and to compare these data to previously published findings.
Recent findings: SSc disease occurrence data are now available for Argentina, Taiwan, and India and continue to show wide variation across geographic regions. The survival rate is negatively impacted by older age of onset, male sex, scleroderma renal crisis, pulmonary fibrosis, pulmonary arterial hypertension, cancer, and antitopoisomerase and anti-U1 antibodies. It appears that silica exposure confers an increased risk for developing scleroderma, but this exposure accounts for a very small proportion of male patients. Smoking is not associated with increased SSc susceptibility. Malignancies are reported in scleroderma at an increased rate, but the magnitude of this risk and the type of cancer vary among reports.
Summary: Prevalence and incidence of SSc appears to be greater in populations of European ancestry and lower in Asian groups. Exposure to silica dust appears to be an environmental trigger, but this only accounts for a small proportion of male cases. Evidence for increased risk of neoplasia is suggestive, but the magnitude of the risk and the types of malignancies vary among reports.
Similar articles
-
Geoepidemiology of systemic sclerosis.Autoimmun Rev. 2010 Mar;9(5):A311-8. doi: 10.1016/j.autrev.2009.11.003. Epub 2009 Nov 10. Autoimmun Rev. 2010. PMID: 19906362 Review.
-
Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.Scand J Rheumatol. 2011;40(5):373-8. doi: 10.3109/03009742.2011.553736. Epub 2011 Mar 9. Scand J Rheumatol. 2011. PMID: 21388247
-
Determinants of morbidity and mortality of systemic sclerosis in Canada.Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15. Semin Arthritis Rheum. 2010. PMID: 18706680
-
Malignancies associated with systemic sclerosis.Autoimmun Rev. 2012 Oct;11(12):852-5. doi: 10.1016/j.autrev.2012.02.021. Epub 2012 Mar 5. Autoimmun Rev. 2012. PMID: 22410174 Review.
-
Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis.J Rheumatol. 2002 Sep;29(9):1867-73. J Rheumatol. 2002. PMID: 12233880
Cited by
-
Acute Spontaneous Colonic Perforation in a Case of Newly Confirmed Scleroderma: Case Report.Interact J Med Res. 2023 Mar 8;12:e43295. doi: 10.2196/43295. Interact J Med Res. 2023. PMID: 36862558 Free PMC article.
-
Identification and Interaction Analysis of Key Genes and MicroRNAs in Systemic Sclerosis by Bioinformatics Approaches.Curr Med Sci. 2019 Aug;39(4):645-652. doi: 10.1007/s11596-019-2086-3. Epub 2019 Jul 25. Curr Med Sci. 2019. PMID: 31347003
-
Risk factors for the development of systemic sclerosis: a systematic review of the literature.Rheumatol Adv Pract. 2018 Oct 11;2(2):rky041. doi: 10.1093/rap/rky041. eCollection 2018. Rheumatol Adv Pract. 2018. PMID: 31431978 Free PMC article.
-
Diagnosis of Simultaneous Atrial and Ventricular Mechanical Performance in Patients with Systemic Sclerosis.Biology (Basel). 2022 Feb 14;11(2):305. doi: 10.3390/biology11020305. Biology (Basel). 2022. PMID: 35205171 Free PMC article.
-
Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?Curr Opin Pulm Med. 2023 Sep 1;29(5):380-390. doi: 10.1097/MCP.0000000000001001. Epub 2023 Jul 14. Curr Opin Pulm Med. 2023. PMID: 37461869 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials